Project Number 2R42AG062001-02A1 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Optimization of small molecule SERCA2b activators to inhibit neuron loss in Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) h. Cell death Researcher and Organization Principal Investigator DAHL, RUSSELL Principal Investigator First Name RUSSELL Principal Investigator Last Name DAHL Awardee Organization NEURODON LLC Awardee State Indiana Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $988,940 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
